Modified geriatric nutritional risk index as a prognostic indicator for patients with intrahepatic cholangiocarcinoma undergoing liver resection
Frontiers in Nutrition · 29.10.2026 · 13
DOI: 10.3389/fnut.2026.1965547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 29.10.2026. Verfasst von Moriyasu Takada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Kansai Medical University, Osaka, Japan. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The modified Geriatric Nutritional Risk Index (mGNRI), which incorporates C-reactive protein (CRP) level and ideal body weight ratio, has been proposed as a prognostic indicator for survival in certain cancers. This study evaluated its association with outcomes in patients with intrahepatic cholangiocarcinoma (ICC) undergoing hepatectomy.
Methods
We retrospectively analyzed 99 patients with ICC who underwent hepatectomy between April 2008 and August 2022. The optimal mGNRI cut-off (88.2) determined by receiver-operating characteristic (ROC) curve analysis, classified patients into low and high mGNRI groups.
Results
Forty-five patients (45.5%) were in the low mGNRI group, and 54 (54.5%) were in the high mGNRI group. The low mGNRI group had a significantly lower body mass index (BMI) and hemoglobin and serum albumin levels, but higher CRP levels compared with the high mGNRI group. Recurrence-free survival (RFS; hazard ratio [HR]: 2.09, 95% confidence interval [CI]: 1.29–3.39, p = 0.003) and overall survival (OS; HR: 2.25, 95% CI: 1.32–3.83, p = 0.003) were both worse in the low mGNRI group than in the high mGNRI group. Multivariate Cox proportional hazards analysis showed that a low mGNRI was an independent prognostic factor for OS (HR: 1.86, 95% CI: 1.03–3.37, p = 0.041). Postoperative dietary intake was significantly lower in the low vs. the high mGNRI group.
Conclusions
The mGNRI has a prognostic impact on patients with ICC after hepatectomy. Patients with a low mGNRI showed poorer survival and a lower postoperative oral energy adequacy ratio, highlighting the importance of perioperative nutritional assessment in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Kansai Medical University, Osaka, Japan.
- Department of Health and Nutrition, Faculty of Health Sciences, Osaka Aoyama University, Minoh, Japan.
- Department of Surgery, Hanoi Medical University, Hanoi, Vietnam.
- Department of Nutrition, Osaka Seiki College, Osaka, Japan.
- Internal Gastroenterology Department, VNU University of Medicine and Pharmacy, Hanoi, Vietnam.
- Department of Hepatobiliary and Gastrointestinal Surgery, Thai Nguyen National Hospital, Thai Nguyen, Vietnam.
Zitieren
APA
Takada, M., Lai, T. T., Inoue, K., Nguyen, V. K., Matsui, K., Yamamoto, H., Kosaka, H., Kiguchi, G., Matsushima, H., Ohigashi, T., Duong, H. H., Yoshii, K., & Kaibori, M. (2026). Modified geriatric nutritional risk index as a prognostic indicator for patients with intrahepatic cholangiocarcinoma undergoing liver resection. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1965547
Vancouver
Takada M, Lai TT, Inoue K, Nguyen VK, Matsui K, Yamamoto H, et al. Modified geriatric nutritional risk index as a prognostic indicator for patients with intrahepatic cholangiocarcinoma undergoing liver resection. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1965547
BibTeX
@article{Takada2026,
author = {Takada, Moriyasu and Lai, Thanh Tung and Inoue, Kyoko and Nguyen, Van Khanh and Matsui, Kosuke and Yamamoto, Hidekazu and Kosaka, Hisashi and Kiguchi, Gozo and Matsushima, Hideyuki and Ohigashi, Takuya and Duong, Hoang Hai and Yoshii, Kengo and Kaibori, Masaki},
title = {Modified geriatric nutritional risk index as a prognostic indicator for patients with intrahepatic cholangiocarcinoma undergoing liver resection},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1965547}
}
EUVIMED